BlueCrest Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

BlueCrest Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,430	Closed	-$87K	–	1570
2018 Q3	$87K	Sell	10,430 -2,569	-20%	-$19.5K	﹤0.01%	1400
2018 Q2	$81K	Buy	+12,999	New	+$82.7K	﹤0.01%	1413
2017 Q3	–	Sell	-30,327	Closed	-$234K	–	1150
2017 Q2	$234K	Buy	+30,327	New	+$256K	0.01%	740
2016 Q3	–	Sell	-40,704	Closed	-$388K	–	1047
2016 Q2	$388K	Buy	+40,704	New	+$443K	0.02%	612
2015 Q2	–	Sell	-14,490	Closed	-$98K	–	964
2015 Q1	$98K	Buy	+14,490	New	+$58.3K	0.01%	585

Other funds holding NPTN

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlueCrest Capital Management's NPTN Position: Q4 2018 in Review

BlueCrest Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2018, closing a stake of 10,430 shares — an estimated $87K sold.

BlueCrest Capital Management first reported a position in NPTN in Q1 2015 and held it in 5 quarters. The position peaked at $388K in Q2 2016. 115 funds tracked by Wall St. Rank hold NPTN as of Q4 2018.

BlueCrest Capital Management reported no remaining NEOPHOTONICS CORP position as of Q4 2018 after selling out during the quarter.
BlueCrest Capital Management sold 10,430 NEOPHOTONICS CORP shares in Q4 2018, an estimated $87K.
BlueCrest Capital Management first reported a position in NEOPHOTONICS CORP in Q1 2015 and held it in 5 quarters.
BlueCrest Capital Management's NEOPHOTONICS CORP position peaked at $388K in Q2 2016.
115 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.